Canada – Press Release: Red Light Holland Announces Filament Health Obtains Interim Order for Proposed Arrangement | Cannabis Law Report | How to order Skittles Moonrock online
Learn where to order CBD Oil online. TOP QUALITY GRADE A++
Cannabyss Inc. is the best place online to buy top quality weed, cannabis, vape, marijuana and CBD products. Get your borderless orders delivered at the pickup spot with ease. Top Grade products for client satisfaction.
👉 Click here to Visit our shop! 🛒
Toronto, Ontario–(Newsfile Corp. – March 23, 2026) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light” or the “Company“) and Filament Health Corp. (OTC: FLHLF) (“Filament“) today announced that, further to the joint press release dated March 10, 2026, the Supreme Court of British Columbia issued an interim order (the “Interim Order“) in connection with the previously announced acquisition by Red Light of all the issued and outstanding common shares of Filament (the “FilamentShares“), pursuant to a statutory plan of arrangement (the “Arrangement“) under the Business Corporations Act (British Columbia). Among other things, the Interim Order authorizes Filament to call, hold and conduct an annual general and special meeting (the “Meeting“) of the holders of Filament Shares (the “FilamentShareholders“) on April 24, 2026 at 8:00 a.m. (Vancouver time) to, among other things, consider and, if thought advisable, pass a special resolution approving, among other things, the Arrangement. The Meeting will be held at the offices of Fasken Martineau DuMoulin LLP at 550 Burrard Street, Suite 2900, Vancouver, British Columbia V6C 0A3.
The receipt of the Interim Order marks an important step forward as both companies continue to advance toward closing. The transaction process is progressing smoothly and in accordance with anticipated timelines.
“We are very pleased to have reached this stage in the process,” said Todd Shapiro, CEO and Director of Red Light. “Both teams remain highly engaged and aligned as we work toward completing this strategic combination.”
Filament Shareholders of record as of the close of business on March 2, 2026 will be entitled to vote at the Meeting. In connection with the Meeting, Filament will be mailing a notice of meeting and management information circular (collectively, the “Circular“), letter of transmittal and related meeting materials (collectively, with the Circular, the “Meeting Materials“), as applicable, to Filament Shareholders. Details on the Meeting and how Filament Shareholders can participate in the Meeting will be set out in the Circular. The Meeting Materials will be made available under Filament’s profile on SEDAR+ at www.sedarplus.ca and on Filament’s website at www.filament.health concurrently with mailing to Filament Shareholders.
The Board of Directors of Filament (the “FilamentBoard“), in consultation with its financial and legal advisors, has determined that the Arrangement is in the best interests of Filament and that the consideration to be received by Filament Shareholders is fair to Filament Shareholders. The Filament Board unanimously recommends that Filament Shareholders vote “FOR” the Arrangement.
Completion of the Arrangement is subject to customary conditions, including court approval, any regulatory approval and the approval of at least two-thirds of the votes cast by the Filament Shareholders present in person or by proxy at the Meeting and a simple majority of votes cast by Filament Shareholders present in person or by proxy at the Meeting, excluding votes attached to Filament Shares held by a Filament Shareholder whose votes are required to be excluded in order to obtain “minority approval” in accordance with Section 8.1 of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions.
Red Light and Filament will continue to provide updates as the transaction progresses.
Leave a Reply
Want to join the discussion?Feel free to contribute!